Clinical Trials
5 trialsNCT04258631 2024-10-16
Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies
Mayo Clinic
Phase 4 Completed
NCT01812759 2021-06-29
Fentanyl for Breakthrough Pain in the Emergency Department
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT02459964 2021-06-16
Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain
M.D. Anderson Cancer Center
Phase 4 Completed
NCT00766831 2013-10-23
An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain
Janssen Korea, Ltd., Korea
Phase 4 Completed
NCT01648699 2013-10-11
Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
Janssen Pharmaceutica
Phase 4 Terminated